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Testicular Microlithiasis: Patient Compliance in a Two-
Year Follow-Up Program
ried out very differently from center to center. 
Recently, the Scrotal Imaging Subcommittee of 
the European Society of Urogenital Radiology 
(ESUR) published a consensus report on TML. 
ESUR presented 2 definitions of TML; 1) 5 or 
more TML in the whole testis, or 2) 5 or more 
TML per field of view. Moreover, the presence of 
TML in the testis, in the absence of other risk fac-
tors, is not considered an indication for annual 
US. The guidelines do, however, recommend US 
follow-up once a year until the age of 55 years in 
men presenting additional risk factors, such as 
personal/family history of testis cancer, unde-
scended testicle, previous orchiopexy or testicu-
lar atrophy [7].
A few studies have focused on follow-up. DeCas-
tro et al. published a 5-year follow-up study of 63 
asymptomatic men with TML, one of whom 
(1.6 %) developed a germ cell tumor after 64 
months [8]. In a recent study, Patel et al. investi-
gated their follow-up program in a single center 
for a period of 14 years with 442 men diagnosed 
Introduction
▼
Testicular microlithiasis (TML) is a relatively 
common finding by ultrasonography (US) of the 
scrotum. There is still some uncertainty whether 
TML should be considered an incidental benign 
finding or regarded as a lesion associated with 
testicular pre-malignancy.
A meta-analysis recently investigated the rela-
tionship between TML and testicular cancer. This 
study included 14 studies with more than 35 000 
patients and found TML significantly associated 
(RR = 12.70, p < 0.001) with risk of developing tes-
ticular cancer [1]. The follow-up period ranged 
between 8.8–61.8 months, but the meta-analysis 
did not report the prevalence. Although some 
studies have found this interrelationship [2–4], 
other investigations have questioned the associa-
tion between TML and the development of tes-
ticular malignancy [5, 6].
As a consequence of this controversy, the clinical 
management of men diagnosed with TML is car-
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Abstract
▼
Introduction: We present a retrospective 
2-year follow-up cohort of 103 men with tes-
ticular microlithiasis (TML) and discuss patient 
compliance and the value of surveillance.
Methods: A retrospective analysis of patients 
examined with scrotal ultrasonography (US) in 
the period from 2008 through 2010 was per-
formed. A total of 103 men with TML were diag-
nosed and offered US follow-up every 6 months 
for 2 years. They were retrospectively analyzed 
regarding demographics and follow-up details, 
including the development of any kind of malig-
nancy until March 2015, using the Danish Elec-
tronic Pathology Registry.
Results: The prevalence of TML was 10.3 %. Of 
the 103 men with TML, 23 (22.3 %) had TML in 
the left testicle, 38 (36.9 %) in the right (p = 0.002), 
and 42 (40.8 %) had bilateral TML. Patient com-
pliance was low with 11.7 % participating in all 
US follow-up examinations. 5 men presented 
risk factors (testicular atrophy (N = 1) and previ-
ous testicular cancer (N = 4)), but no cases of tes-
ticular malignancy were found in the follow-up 
period.
Conclusion: The low patient compliance con-
flicts with the ESUR Scrotal Imaging Subcommit-
tee guidelines that recommend scrotal US 
follow-up annually for TML until the age of 55 
years. The fact that no cancers were found during 
follow-up using the pathology registry calls the 
value of follow-up into question.
THIEME
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with TML (prevalence 4.3 %) in a population of more than 20 000 
men. In the follow-up period, 2 men (0.5 %) developed a testicu-
lar germ cell tumor [9]. Richenberg and Brejt performed a litera-
ture study with 2 656 men referred to scrotal US, and 51 (1.9 %) 
were diagnosed with TML. None of these developed testicular 
cancer with a mean follow-up period of 33.3 months [10]. A 
newly published study from 2015 investigated 1 249 patients 
with testicular cancer and found that 346 had TML. In total, 51 % 
(175 out of 346) had one or more microliths and 20 % (69 out of 
346) had more than 5 microliths per field of view. This investiga-
tion concluded that patients with TML may be more likely to 
have seminomas than embryonal components in their primary 
tumor [11].
The aim of this study was to investigate a 2-year follow-up pro-
gram in patients with TML in order to evaluate patient compli-
ance. The secondary aim, using the Danish Electronic Pathology 
Registry (i. e., Patobanken), was to investigate if any of the 
patients developed testicular pre-malignancy and/or manifested 
invasive testicular cancer.
Materials and Methods
▼
The study was conducted as a retrospective review of the TML 
follow-up program implemented at the Department of Radiol-
ogy, Lillebaelt Hospital, Denmark. Men diagnosed with TML 
were offered scrotal US follow-up every 6 months for a period of 
2 years.
TML was defined as; 1) classic TML with 5 or more microliths per 
testis or 2) limited TML with fewer than 5 microliths. All US 
reports were identified in the period from 2008 through 2010, 
using the available database (Picture Archive Communication 
System (PACS), Easyviz Impax Workstation, Medical Insight, 
Valby, Denmark).
All patients had scrotal US examination performed by experi-
enced senior radiologists, or by experienced sonographers 
trained in testicular US. US was performed using one of 3 scan-
ners: 2 kinds of 9L4 linear array transducer (Siemens, Acuson, 
S2000, Mountain View, CA or Siemens, Acuson, S3000, Mountain 
View, CA) and a 14-6 linear array transducer (Hitachi, EUB-8500, 
Tokyo, Japan). A series of images had been recorded in PACS at 
each examination as a standard procedure. All included cases 
were retrospectively reviewed to collect demographic data, indi-
cations for US, US results and follow-up information, including 
the development of testicular abnormalities. When TML was 
diagnosed, a follow-up scan every 6 months in a 2-year period 
was recommended in the US report. The US report was sent to 
the patient’s general practitioner.
Pre-malignant and malignant testicular lesions were identified 
using the Danish Electronic Pathology Registry. This registry 
contains all histo- and cyto-pathological, SNOMED-based diag-
noses of Danish citizens since the 1980s. The registry is used in 
the daily diagnostic routine by Danish pathologists, and it is the 
foundation of the Danish Cancer Registry. Moreover, the registry 
forms the basis for producing statistics and carrying out quality 
control. All men diagnosed with TML were followed until March 
2015.
The study was approved by the Danish Data Protection Agency 
and The Regional Scientific Ethical Committees for Southern 
Denmark (ID#: S-20120144).
Results
▼
A total of 1 005 patients with scrotal US examinations were 
retrieved from PACS and 103 adult men and 2 boys were diag-
nosed with TML. The 2 boys were excluded from the study. The 
clinical indications for the baseline US are summarized in  ●▶  Fig. 
1, testicular pain being the most frequent cause of referral to 
scrotal US.
The prevalence of TML was 10.3 %, with a mean age of 42 (range 
19–80) years. In addition to TML, US diagnoses are specified 
in  ●▶  Table 1.
A total of 23 men (22.3 %) had TML in the left testicle, 38 (36.9 %) 
in the right (p = 0.02), and 42 (40.8 %) had bilateral TML.  ●▶  Table 
2 shows the distribution of TML at baseline US.
All 103 men were offered entry into the US follow-up program 
by the radiologist at the baseline US scan. At the subsequent US 
scan, the radiologist offered a new US scan after a time period of 
6 months. However, only 12 men (11.7 %) participated in the full 
2-year follow-up program ( ●▶  Fig. 2). 6 of these 12 men (50 %) had 
1–4 TML, 3 (25 %) had 5–10 TML, 2 (16.7 %) had multiple TML, 
and 1 man (8.3 %) diagnosed with 1–4 TML at baseline US expe-
rienced disappearance of the TML at the final US follow-up.
0
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Fig. 1 Clinical indications in 103 men with testicular microlithiasis for 
referral to scrotal ultrasonography.
Table 1 Overview of additional diagnoses from the scrotal ultrasonography 
(US) diagnoses at the baseline scans in the 103 men with testicular microlithi-
asis (TML).
Diagnosis  ≤ 40 years
46 men
40 years
57 men
Total
103 men
Spermatocele 19 22 41
Hydrocele 4 12 16
Varicocele 5 14 19
Epididymitis 3 2 5
Testicular atrophy 1 3 4
Inguinal hernia – 5 5
Previously orchiectomy 1 1 2
Granuloma – 2 2
Suspicion of testicular tumor or 
carcinoma in situ
5 1 6
No additional US diagnosis 14 14 28
Some men had more than one additional diagnosis
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A total of 13 of the 103 men were referred to further investiga-
tion at the Department of Urology, Lillebaelt Hospital, Denmark, 
10 at the baseline US and 3 men later in the follow-up US pro-
gram. These men were referred either because of multiple TML 
(N = 5), the clinical suspicion of carcinoma in situ (N = 3), testicu-
lar cancer (N = 3), atrophy (N = 1) or varicocele (N = 1). 2 of the 13 
men, referred at baseline US, had a final histopathological diag-
nosis of testicular cancer. According to the clinical records, one 
of these patients had previously been diagnosed with testicular 
cancer in the right testicle in 2006, and was now diagnosed with 
cancer in the left testicle, in which baseline US had shown sev-
eral TML. The other patient, diagnosed with cancer in the right 
testicle at baseline US, had between 5–10 bilateral TML. After 
the right-sided orchiectomy, the patient never returned to the 
US follow-up program. 3 other men from the referral group of 13 
men underwent testicular biopsy on the clinical suspicion of 
pre-malignant or malignant testicular lesion. The histopatho-
logical examination of their biopsies showed, however, no signs 
of malignancy.
Searching the Danish Electronic Pathology Registry revealed 
that none of the remaining 101 men with TML were diagnosed 
with testicular cancer in the follow-up period until March 2015. 
3 men with a mean age of 62.2 (range 50–70) years were diag-
nosed with prostate cancer in 2009, 2010 and 2011, respectively. 
Moreover, one man was diagnosed with pancreatic cancer in 
2012. 8 patients had undergone sterilization before 2008, i. e., 
before inclusion in the study at baseline US. None of these 
revealed any pathology in the follow-up period.
5 men with recognized risk factors of developing testicular can-
cer were detected in the study ( ●▶  Table 3). Apart from the 2 men 
diagnosed with testicular cancer at baseline US, 2 other men had 
previously, before inclusion in the present study, been diagnosed 
with testicular cancer, and none developed testicular cancer in 
the follow-up period. All 103 patients could be identified in the 
Danish Electronic Pathology Registry.
Discussion
▼
The TML prevalence of 10.3 % in the present study population of 
1 005 patients ranges within the upper part of previously 
reported TML prevalence. A literature survey documents an esti-
mated prevalence between 0.6–9.0 % [12–15]. Differences in 
study population, e. g., size and age distribution, and research 
focus may offer explanations regarding the variations in TML 
prevalence in published studies.
The priority given by the 103 men with TML to participate in the 
offered US follow-up schedule seems rather low. It was the 
radio logist’s responsibility to offer US follow-up to the patients. 
If this recommendation was only offered orally, this may cause a 
lower participation rate in the follow-up program. Moreover, if 
symptoms were absent after 6 months, there is a potential risk 
that patients tend to skip continuation of the follow-up. US 
examinations in Denmark are free of payment, and in our 
Department of Radiology the patients are offered direct access 
to US on a day-to-day basis. Thus, no financial burden hinders 
the men from participating.
It will most likely be a clinical challenge to increase compliance 
in this group of men regarding their participation in annual US. 
Moreover, the follow-up participation rate will probably be very 
low, if the annual scrotal US continues over an extended time 
period until the age of 55 years. This prolonged “screening pro-
gram” will also produce unnecessary patient distress and anxi-
ety, which may not correspond with any real clinical benefit for 
the patient. Consequently, one may question the clinical rele-
vance, patient compliance and cost-benefit of the US follow-up 
program suggested by the ESUR Scrotal Imaging Subcommittee.
Some studies have reported that bilateral TML increases the risk 
of developing testicular cancer [16, 17], but so far no clear asso-
ciation has been proved. We found 42 (40.8 %) patients with 
bilateral TML, and one of those was diagnosed with testicular 
cancer at the baseline US.
13 men were referred to further investigation at the Department 
of Urology, and 2 were diagnosed with testicular cancer at their 
baseline US, whereas we did not detect any men in the study 
group who developed testicular neoplasia within the US follow-
up period. All ultrasound reports of the 103 patients were sub-
sequently reviewed. Besides the 13 men referred to further 
investigation at the Department of Urology, none of the remain-
ing men in the study had a diagnosis of testicular neoplasia 
according to the Danish Electronic Pathology Registry. The cov-
erage and precision of classification in this national registry are 
extremely high, and it can be concluded that none of the investi-
gated men developed testicular germ cell neoplasia within a 
minimal time frame of 50 months (range: 50–86 months) after 
conclusion of the US follow-up program. Thus, we detected one 
man with atrophic testis and 4 men with testicular cancer diag-
Table 2 Grading of testicular microlithiasis (TML) at the baseline scrotal 
ultrasonography (US) in men with bilateral TML.
Grading of TML at baseline ultrasonography Number of men ( %)
Some (1–4) 60 (58.3 %)
Several (5–10) 25 (24.3 %)
Multiple (11 + ) 15 (14.5 %)
Number not reported 3 (2.9 %)
Total 103 (100 %)
The numbers refer to the testicle with the highest amount of TML
103
21 15 11 12
0
20
40
60
80
100
120
Baseline 6 months 12 months 18 months 24 months
2-year follow-up
Fig. 2 Number of men participating in the follow-up program.
Table 3 Risk factors encountered among 103 men diagnosed with testicular 
microlithiasis (TML).
Risk factors Number 
of patients 
with TML
Number of patients 
developing testicular can-
cer during US follow-up
Testicular atrophy 1 0
Previous testicular cancer 4 0 * 
 * One man with previously diagnosed, right-sided testicular cancer in 2006 was diag-
nosed with cancer in the remaining left testicle at the baseline ultrasonography (US)
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nosed previously or at baseline US. According to the Danish Elec-
tronic Pathology Registry, none of these men developed 
testicular germ cell neoplasia in the follow-up until March 2015.
The incidence of testicular cancer is more than 3 times as high in 
men aged 15–35 years than among men above the age of 50 
years. The age distribution of our study population has a mean of 
42 years. Accordingly, our study population is representative 
and includes the high-risk group. Moreover, we examined the 
diagnostic differences between men in 2 age groups. In the 
group of men ≤ 40 years, the diagnostic suspicion of malignant 
testicular tumor/carcinoma in situ was detected 5 times, as com-
pared to only one time in the age group  > 40 years. Because our 
study population only consists of 103 men with TML, we did not 
expect any of them to develop testicular cancer.
A limitation of the present study is the lack of a clear definition 
of TML. The ESUR guidelines state 2 definitions – 5 TML or more 
in the testis or per field of view. The cut-off point of 5 TML has 
been broadly accepted in the literature, but on the other hand 
many studies make use of the definition classic or limited TML 
[18–21]. One could argue that the presence of a risk factor, and 
not the number of TML, should determine if the follow-up pro-
gram should be offered. Therefore, we have chosen to imple-
ment both the limited and the classic definition of TML. A recent 
study investigated 346 testicular tumors and found that 51 % had 
one or more microliths per image [11]. This finding may offer an 
argument for not disregarding men with limited TML. Another 
limitation of our retrospective study is that we did not discrimi-
nate between age groups, and high- vs. low-risk patients. The 
reason for this is that the study was initiated prior to the ESUR 
guidelines [7], which explains the inclusion of some men older 
than the recommended limit of 55 years.
Our main focus was to study patient compliance, and the sec-
ondary aim was to disclose any development of testicular malig-
nancy in a 2-year follow-up program. The relatively short 
observation period for developing testicular malignancy (50–86 
months) after baseline US represents a limitation of our study. 
On the other hand, a recent meta-analysis had an even shorter 
follow-up period ranging between 8.8 and 61.8 months [1]. The 
strength of our study was the opportunity to follow all men 
diagnosed with TML within the framework of the Danish Elec-
tronic Pathology Registry simply by using the unique Central 
Personal Registration Number, which is provided to every citizen 
in Denmark. This registration number is linked to all medical 
records and official registries and can thus be used e. g., to find 
information on any diagnosed cancer.
In conclusion, our findings suggest low patient compliance for 
participating in a scrotal US follow-up program in the event of 
diagnosed TML. Accordingly, annual follow-up US may be diffi-
cult to implement in clinical practice. Furthermore, this study 
cannot discern any correlation between TML and later occur-
rence of testicular germ cell neoplasia.
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